Both net sales and operating income were higher than both the previous year's levels and the forecasts, as steady sales from existing businesses and M&As contributed to the sales growth, while robust investments and strong performance towards the end of the fiscal year, in particular, contributed to the operating income growth.
Year ended
Year ended
Year ended
Compared to
Y/Y
Mar. 31, 2019
Mar. 31, 2018
Mar. 31, 2019
forecasts
(Forecasts)
Net sales
50,499
53,986
+6.9%
53,000
+1.9%
Operating
4,023
4,268
+6.1%
4,200
+1.6%
income
Ordinary
4,311
4,215
-2.2%
4,250
-0.8%
income
Net income
3,050
2,859
-6.3%
2,900
-1.4%
attributable to
owners of parent
EPS (Yen)
76.08
69.47
-
-
-
ROA (%)
7.6
6.6
-
-
-
(Note) A 2-for-1 stock split of the Company's outstanding shares of common stock implemented on October 1, 2017 is factored into EPS figures.
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original document
Permalink
Disclaimer
Intage Holdings Inc. published this content on 28 May 2019 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 28 May 2019 11:08:07 UTC
INTAGE HOLDINGS Inc., formerly INTAGE Inc., is a provider of marketing research and consulting services. The Market Research and Consulting segment is engaged in marketing research operations, including customer panel research, retail shop panel research and other research activities; customized research services, including Internet research, mail survey, visiting interview survey and qualitative research, as well as the provision of related consulting services. The System Solution segment is engaged in the development and sale of software, the operation of systems and data centers, and the provision of various related consulting services. The Drug Development Support segment is engaged in the contract research organization (CRO) business. As of March 31, 2014, the Company had 24 subsidiaries and one associated company.